Sökning: WFRF:(Uhlén Mathias)
> (2020-2024) >
Combined Metabolic ...
Combined Metabolic Activators with Different NAD+ Precursors Improve Metabolic Functions in the Animal Models of Neurodegenerative Diseases
-
- Altay, Özlem (författare)
- KTH,Systembiologi,Science for Life Laboratory, SciLifeLab
-
- Yang, Hong (författare)
- KTH,Systembiologi,Science for Life Laboratory, SciLifeLab
-
- Yildirim, Serkan (författare)
- Department of Pathology, Faculty of Veterinary Medicine, Atatürk University, Erzurum 25240, Turkey;
-
visa fler...
-
- Bayram, Cemil (författare)
- Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Atatürk University, Erzurum 25240, Turkey;
-
- Bolat, Ismail (författare)
- Department of Pathology, Faculty of Veterinary Medicine, Atatürk University, Erzurum 25240, Turkey;
-
- Oner, Sena (författare)
- Department of Molecular Biology and Genetics, Faculty of Science, Erzurum Technical University, Erzurum, 25240, Turkey
-
- Tozlu, Ozlem Ozdemir (författare)
- Department of Molecular Biology and Genetics, Faculty of Science, Erzurum Technical University, Erzurum, 25240, Turkey
-
- Arslan, Mehmet Enes (författare)
- Department of Molecular Biology and Genetics, Faculty of Science, Erzurum Technical University, Erzurum, 25240, Turkey
-
- Hacimuftuoglu, Ahmet (författare)
- Department of Medical Pharmacology, Faculty of Medicine, Atatürk University, Erzurum 25240, Turkey;
-
- Shoaie, Saeed (författare)
- Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King’s College London, London, SE1 9RT, UK
-
- Zhang, Cheng (författare)
- KTH,Systembiologi,Science for Life Laboratory, SciLifeLab
-
- Borén, Jan, 1963 (författare)
- Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine
-
- Uhlén, Mathias (författare)
- KTH,Systembiologi,Science for Life Laboratory, SciLifeLab
-
- Turkez, Hasan (författare)
- Department of Medical Biology, Faculty of Medicine, Atatürk University, Erzurum 25240, Turkey;
-
- Mardinoglu, Adil (författare)
- KTH,Systembiologi,Science for Life Laboratory, SciLifeLab,Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King’s College London, London, SE1 9RT, UK
-
visa färre...
-
(creator_code:org_t)
- MDPI AG, 2024
- 2024
- Engelska.
-
Ingår i: Biomedicines. - : MDPI AG. - 2227-9059. ; 12:4
- Relaterad länk:
-
https://doi.org/10.3...
-
visa fler...
-
https://urn.kb.se/re...
-
https://doi.org/10.3...
-
https://gup.ub.gu.se...
-
visa färre...
Abstract
Ämnesord
Stäng
- Background: Mitochondrial dysfunction and metabolic abnormalities are acknowledged as significant factors in the onset of neurodegenerative disorders such as Parkinson’s disease (PD) and Alzheimer’s disease (AD). Our research has demonstrated that the use of combined metabolic activators (CMA) may alleviate metabolic dysfunctions and stimulate mitochondrial metabolism. Therefore, the use of CMA could potentially be an effective therapeutic strategy to slow down or halt the progression of PD and AD. CMAs include substances such as the glutathione precursors (L-serine and N-acetyl cysteine), the NAD+ precursor (nicotinamide riboside), and L-carnitine tartrate. Methods: Here, we tested the effect of two different formulations, including CMA1 (nicotinamide riboside, L-serine, N-acetyl cysteine, L-carnitine tartrate), and CMA2 (nicotinamide, L-serine, N-acetyl cysteine, L-carnitine tartrate), as well as their individual components, on the animal models of AD and PD. We assessed the brain and liver tissues for pathological changes and immunohistochemical markers. Additionally, in the case of PD, we performed behavioral tests and measured responses to apomorphine-induced rotations. Findings: Histological analysis showed that the administration of both CMA1 and CMA2 formulations led to improvements in hyperemia, degeneration, and necrosis in neurons for both AD and PD models. Moreover, the administration of CMA2 showed a superior effect compared to CMA1. This was further corroborated by immunohistochemical data, which indicated a reduction in immunoreactivity in the neurons. Additionally, notable metabolic enhancements in liver tissues were observed using both formulations. In PD rat models, the administration of both formulations positively influenced the behavioral functions of the animals. Interpretation: Our findings suggest that the administration of both CMA1 and CMA2 markedly enhanced metabolic and behavioral outcomes, aligning with neuro-histological observations. These findings underscore the promise of CMA2 administration as an effective therapeutic strategy for enhancing metabolic parameters and cognitive function in AD and PD patients.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Neurovetenskaper (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Neurosciences (hsv//eng)
Nyckelord
- Alzheimer’s disease
- animal models
- combined metabolic activators
- Parkinson’s disease
- Alzheimer's disease
- Parkinson's disease
- combined metabolic activators
- animal models
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Altay, Özlem
-
Yang, Hong
-
Yildirim, Serkan
-
Bayram, Cemil
-
Bolat, Ismail
-
Oner, Sena
-
visa fler...
-
Tozlu, Ozlem Ozd ...
-
Arslan, Mehmet E ...
-
Hacimuftuoglu, A ...
-
Shoaie, Saeed
-
Zhang, Cheng
-
Borén, Jan, 1963
-
Uhlén, Mathias
-
Turkez, Hasan
-
Mardinoglu, Adil
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Medicinska och f ...
-
och Neurovetenskaper
- Artiklar i publikationen
-
Biomedicines
- Av lärosätet
-
Kungliga Tekniska Högskolan
-
Göteborgs universitet